Figure 7From: Clinical implications of novel activating EGFR mutations in malignant peritoneal mesotheliomaQuantitative analysis of phosphorylation in COS-7 cell transfectants expressing mutant EGFR following treatment with Erlotinib. Autoradiographs of three independent experiments were quantified. The intensity of EGFR phosphorylation has been adjusted for total EGFR expression. Error bars denote standard deviation.Back to article page